YYD302 2ml

DRUG2 trials

Sponsors

Yooyoung Pharmaceutical Co., Ltd.

Conditions

Osteoarthritis, Knee

Phase 1

Clinical Trial of YYD302 for Treatment of Osteoarthritis of the Knee

CompletedNCT02965495

Yooyoung Pharmaceutical Co., Ltd.Osteoarthritis, Knee

Start: 2016-11-30End: 2017-09-30Target: 30Updated: 2017-12-11

Phase 3

Clinical Trial of YYD302 (Phase3) for Treatment of Osteoarthritis of the Knee

CompletedNCT03561779

Yooyoung Pharmaceutical Co., Ltd.Osteoarthritis, Knee

Start: 2018-02-21End: 2019-10-04Updated: 2021-05-10

Related Papers

Intra-Articular Injection of a Novel DVS Cross-Linked Hyaluronic Acid Manufactured by Biological Fermentation (YYD302) in Patients With Knee Osteoarthritis: A Double-Blind, Randomized, Multicenter, Noninferiority Study.

2021-11-019 citations